411 research outputs found
Thirty Years of Cometary Spectroscopy from McDonald Observatory
We report on the results of a spectroscopic survey of 130 comets that was
conducted at McDonald observatory from 1980 through 2008. Some of the comets
were observed on only one night, while others were observed repeatedly. For 20
of these comets, no molecules were detected. For the remaining 110 comets, some
emission from CN, OH, NH, C, C, CH, and NH molecules were
observed on at least one occasion. We converted the observed molecular column
densities to production rates using a Haser (1957) model. We defined a
restricted data set of comets that had at least 3 nights of observations. The
restricted data set consists of 59 comets. We used ratios of production rates
to study the trends in the data. We find two classes of comets: typical and
carbon-chain depleted comets. Using a very strict definition of depleted
comets, requiring C \underline{and} C to both be depleted, we find
9% of our restricted data set comets to be depleted. Using a more relaxed
definition that requires only C to be below a threshold (similar to other
researchers), we find 25% of the comets are depleted. Two-thirds of the
depleted comets are Jupiter Family comets, while one-third are Long Period
comets. 37% of the Jupiter Family comets are depleted, while 18.5% of the Long
Period comets are depleted. We compare our results with other studies and find
good agreement.Comment: Accepted for Icarus; 15 figures, 9 tables (some multi-page and in
landscape mode
Green functions for generalized point interactions in 1D: A scattering approach
Recently, general point interactions in one dimension has been used to model
a large number of different phenomena in quantum mechanics. Such potentials,
however, requires some sort of regularization to lead to meaningful results.
The usual ways to do so rely on technicalities which may hide important
physical aspects of the problem. In this work we present a new method to
calculate the exact Green functions for general point interactions in 1D. Our
approach differs from previous ones because it is based only on physical
quantities, namely, the scattering coefficients, and , to construct .
Renormalization or particular mathematical prescriptions are not invoked. The
simple formulation of the method makes it easy to extend to more general
contexts, such as for lattices of general point interactions; on a line; on
a half-line; under periodic boundary conditions; and confined in a box.Comment: Revtex, 9 pages, 3 EPS figures. To be published in PR
Dynamic Evolution Model of Isothermal Voids and Shocks
We explore self-similar hydrodynamic evolution of central voids embedded in
an isothermal gas of spherical symmetry under the self-gravity. More
specifically, we study voids expanding at constant radial speeds in an
isothermal gas and construct all types of possible void solutions without or
with shocks in surrounding envelopes. We examine properties of void boundaries
and outer envelopes. Voids without shocks are all bounded by overdense shells
and either inflows or outflows in the outer envelope may occur. These
solutions, referred to as type void solutions, are further
divided into subtypes and
according to their characteristic behaviours across the sonic critical line
(SCL). Void solutions with shocks in envelopes are referred to as type
voids and can have both dense and quasi-smooth edges.
Asymptotically, outflows, breezes, inflows, accretions and static outer
envelopes may all surround such type voids. Both cases of
constant and varying temperatures across isothermal shock fronts are analyzed;
they are referred to as types and
void shock solutions. We apply the `phase net matching procedure' to construct
various self-similar void solutions. We also present analysis on void
generation mechanisms and describe several astrophysical applications. By
including self-gravity, gas pressure and shocks, our isothermal self-similar
void (ISSV) model is adaptable to various astrophysical systems such as
planetary nebulae, hot bubbles and superbubbles in the interstellar medium as
well as supernova remnants.Comment: 24 pages, 13 figuers, accepted by ApS
A Measurement of Psi(2S) Resonance Parameters
Cross sections for e+e- to hadons, pi+pi- J/Psi, and mu+mu- have been
measured in the vicinity of the Psi(2S) resonance using the BESII detector
operated at the BEPC. The Psi(2S) total width; partial widths to hadrons,
pi+pi- J/Psi, muons; and corresponding branching fractions have been determined
to be Gamma(total)= (264+-27) keV; Gamma(hadron)= (258+-26) keV, Gamma(mu)=
(2.44+-0.21) keV, and Gamma(pi+pi- J/Psi)= (85+-8.7) keV; and Br(hadron)=
(97.79+-0.15)%, Br(pi+pi- J/Psi)= (32+-1.4)%, Br(mu)= (0.93+-0.08)%,
respectively.Comment: 8 pages, 6 figure
Measurement of the B0-anti-B0-Oscillation Frequency with Inclusive Dilepton Events
The - oscillation frequency has been measured with a sample of
23 million \B\bar B pairs collected with the BABAR detector at the PEP-II
asymmetric B Factory at SLAC. In this sample, we select events in which both B
mesons decay semileptonically and use the charge of the leptons to identify the
flavor of each B meson. A simultaneous fit to the decay time difference
distributions for opposite- and same-sign dilepton events gives ps.Comment: 7 pages, 1 figure, submitted to Physical Review Letter
Eculizumab exposure in children and young adults: indications, practice patterns, and outcomes—a Pediatric Nephrology Research Consortium study
Background: Eculizumab is approved for the treatment of atypical hemolytic uremic syndrome (aHUS). Its use off-label is frequently reported. The aim of this study was to describe the broader use and outcomes of a cohort of pediatric patients exposed to eculizumab. Methods: A retrospective, cohort analysis was performed on the clinical and biomarker characteristics of eculizumab-exposed patients < 25 years of age seen across 21 centers of the Pediatric Nephrology Research Consortium. Patients were included if they received at least one dose of eculizumab between 2008 and 2015. Traditional summary statistics were applied to demographic and clinical data. Results: A total of 152 patients were identified, mean age 9.1 (+/−6.8) years. Eculizumab was used “off-label” in 44% of cases. The most common diagnoses were aHUS (47.4%), Shiga toxin-producing Escherichia coli HUS (12%), unspecified thrombotic microangiopathies (9%), and glomerulonephritis (9%). Genetic testing was available for 60% of patients; 20% had gene variants. Dosing regimens were variable. Kidney outcomes tended to vary according to diagnosis. Infectious adverse events were the most common adverse event (33.5%). No cases of meningitis were reported. Nine patients died of noninfectious causes while on therapy. Conclusions: This multi-center retrospective cohort analysis indicates that a significant number of children and young adults are being exposed to C5 blockade for off-label indications. Dosing schedules were highly variable, limiting outcome conclusions. Attributable adverse events appeared to be low. Cohort mortality (6.6%) was not insignificant. Prospective studies in homogenous disease cohorts are needed to support the role of C5 blockade in kidney outcomes
Use of SMS texts for facilitating access to online alcohol interventions: a feasibility study
A41 Use of SMS texts for facilitating access to online alcohol interventions: a feasibility study
In: Addiction Science & Clinical Practice 2017, 12(Suppl 1): A4
Mapping child growth failure across low- and middle-income countries
Childhood malnutrition is associated with high morbidity and mortality globally1. Undernourished children are more likely to experience cognitive, physical, and metabolic developmental impairments that can lead to later cardiovascular disease, reduced intellectual ability and school attainment, and reduced economic productivity in adulthood2. Child growth failure (CGF), expressed as stunting, wasting, and underweight in children under five years of age (0�59 months), is a specific subset of undernutrition characterized by insufficient height or weight against age-specific growth reference standards3�5. The prevalence of stunting, wasting, or underweight in children under five is the proportion of children with a height-for-age, weight-for-height, or weight-for-age z-score, respectively, that is more than two standard deviations below the World Health Organization�s median growth reference standards for a healthy population6. Subnational estimates of CGF report substantial heterogeneity within countries, but are available primarily at the first administrative level (for example, states or provinces)7; the uneven geographical distribution of CGF has motivated further calls for assessments that can match the local scale of many public health programmes8. Building from our previous work mapping CGF in Africa9, here we provide the first, to our knowledge, mapped high-spatial-resolution estimates of CGF indicators from 2000 to 2017 across 105 low- and middle-income countries (LMICs), where 99 of affected children live1, aggregated to policy-relevant first and second (for example, districts or counties) administrative-level units and national levels. Despite remarkable declines over the study period, many LMICs remain far from the ambitious World Health Organization Global Nutrition Targets to reduce stunting by 40 and wasting to less than 5 by 2025. Large disparities in prevalence and progress exist across and within countries; our maps identify high-prevalence areas even within nations otherwise succeeding in reducing overall CGF prevalence. By highlighting where the highest-need populations reside, these geospatial estimates can support policy-makers in planning interventions that are adapted locally and in efficiently directing resources towards reducing CGF and its health implications. © 2020, The Author(s)
- …